Gamida Cell announced today the successful results of the Phase I/II
study of its second pipeline product NiCord, umbilical cord derived stem
cells expanded using the company’s proprietary ... read more
Gamida Cell announced today that its flagship product, StemEx, reached
its primary endpoint of improving overall survival in a Phase II/III
study which compared the use of StemEx ... read more